The use of metabolic hepatoprotective infusion drug remaxol in the treatment of patients with alcohol dependence (literature review)
https://doi.org/10.30629/2613-6667-2013-79-95-99
Abstract
Aim: to present the summary of the results of available Russian studies on the use of hepatotropic infusion drug remaxol in treatment of patients with alcohol dependence.
Method: systematic review.
Results: the positive changes were observed when remaxol was added to combination treatment of acute alcohol intoxication, alcohol withdrawal syndrome and post-withdrawal disorders complicated by hepatic lesions of both alcoholic and non-alcoholic etiology (chronic hepatitis В and C, non-alcoholic steatohepatitis). The use of remaxol results in reduction of incidence of delirium tremens and reduces the duration of the treatment course.
Conclusion: the represented data can be taken as recommendations to be used by physicians in routine clinical practice.
About the Authors
A. G. Gofman
Moscow Research Institute of Psychiatry — branch of'V.P. Serbsky National Medical Research Centre for Psychiatry and Addiction, Ministry of Health of Russian Federation
Russian Federation
Russian Federation
Alexander G. Gofman - Dr. of Sci. (Med.), professor, head of the department for therapy of mental disorders complicated by addictions.
Moscow.
Р. A. Ponizovskiy
Moscow Research Institute of Psychiatry — branch of'V.P. Serbsky National Medical Research Centre for Psychiatry and Addiction, Ministry of Health of Russian Federation
Russian Federation
Russian Federation
Pavel A. Ponizovskiy - Cand. of Sci. (Med.), senior researcher of the department for therapy of mental disorders complicated by addictions.
Moscow.
References
1. Hazanov В.А. Farmakologicheskaya regulyaciya ehnergeticheskogo obmena. Eksperinvntal'naya i klinicheskay farmakologiya. 2009;72(4):61-64. (In Russ.). DOI: 10.30906/0869-2092-2009-72-4-61-64
2. Suhanov D.S., Savateeva T.N. Antioksidantnaya aktivnost' remaksola na modeli lekarstvennogo porazheniya pecheni. Vestnik SPbGMA im. I.I. Mechnikova. 2008;29(4):127-131. (In Russ.).
3. Sologub T.V., Goryacheva L.G., Suhanov D.S. i soavt Gepatoprotektivnaya aktivnost' remaksola pri hronicheskih porazheniyah pecheni (materialy mnogocentrovogo randomizirovannogo placebokontroliruemogo issledovaniya). Klinicheskaya medicina. 2010;88(1):62-66. (In Russ.).
4. Suhanov D.S., Kovalenko A.L., Romancov M.G. i soavt Citoprotektornaya aktivnost'sukcinatsoderzhashchih preparatov na funkcionalnuyu aktivnost' pecheni v ehksperimente. Eksperimental’naya i klinicheskaya farmakologiya. 2010; 73(8):35-39. (In Russ.). DOI: 10.30906/0869-2092-2010-73-8-35-38
5. Vinnikova M.A., Utkin S.L., Nenast'eva A.Yu., Zaharov M.V. Effektivnost' vklyucheniya remaksola v terapiyu alkogolnogo abstinentnogo sindroma. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2016;116(1):40-46. (In Russ.). DOI: 10.17116/jnevro20161161140-46
6. Bohan N.A., Abolonin A.F., Ankudinova I.E., Mendel A.I. Primenenie remaksola v kompleksnoj terapii postabstinentnyh rasstrojstvu bolnyh alkogolizmom s komorbidnym porazheniem pecheni. Terapevticheskij arhiv. 2012;84(10):51-55. (In Russ.).
7. Shilov V.V., Shikalova L.A., Vasifev S.A. i soavt Osobennosti farmakologicheskoj korrekcii toksicheskih porazhenij pecheni u bolnyh s sindromom zavisimosti ot alkogolya i tyazhelymi formami ostryh otravlenij ehtanolom. Zhurnal nevrologii i psihiatrii im. S.S. Korsakova. 2012;112(1):45-48. (In Russ.).
8. Livanov G.A., Shikalova I.A., Lodyagin A.N„ Glushkov S.I, Batocyrenov B.V., Loladze A.T., Kovalenko A.L. Osobennosti farmakologicheskoj korrekcii alkogolnoj zhirovoj distrofii pecheni u bol'nyh s ostrymi otravleniyami ehtanolom. Eksperimentat'naya i klinicheskaya gastroehnterologiya. 2016 ;12 9 (5) :45—50.
9. Gridchik I.E., Kurdyakov A.V., Matveev A.I. Opyt primeneniya gepatoprotektora «Remaksol» v lechenii cirroza pecheni. Eksperimentat'naya i klinicheskaya farmakologiya. 2015;78(1)2:11-14.(In Russ.). DOI:10.30906/0869-2092-2015-78-12-11-14
10. Rudakova A.V. Farmakoehkonomicheskie aspekty korrekcii toksicheskih porazhenij pecheni u bol'nyh s sindromom zavisimosti ot alkogolya i tyazhelymi formami ostryh otravlenij ehtanolom. Klinicheskaya farmakotogiya i terapiya. 2013;22(1):82—84. (In Russ.).
11. Mazina N.K., Mazin P.V., Suhanov D.S. Klinicheskaya effektivnost' sukcinatsoderzhashchego infuzionnogo preparata pri farmakoterapii porazhenij pecheni raznogo geneza: rezultaty metaanaliza. Terapevticheskij arhiv. 2013;85(1):56-61. (In Russ.).
12. Zaplutanov V.A., Spikina A A., Belov V.G, Parfyonov Yu.A., Ermishin E.V. Vozrastnaya specifika metabolicheskoj terapii alkogolnoj zavisimosti u pacientov pozhilogo vozrasta s uchetom ih akmeologicheskih osobennostej. Uspekhi gerontotogii. 2015;28(2):374-380. (In Russ.).
13. Suhanov D.S., Artyushkova E.B., Dudka V.T., Okovityj S.V. Effektivnost' remaksola i ademetionina pri sochetannom eksperimentalnom porazhenii pecheni protivotuberkuleznymi preparatami rezervnogo ryada i alkogolem. Tuberkulez i bolezni legkih. 2014;91(4):59-62. (In Russ.). DOI: 10.21292/2075-1230-2014-0-4-20-28.
Review
For citations:
Gofman A.G., Ponizovskiy Р.A. The use of metabolic hepatoprotective infusion drug remaxol in the treatment of patients with alcohol dependence (literature review). Psychiatry (Moscow) (Psikhiatriya). 2018;(79):95-99. (In Russ.) https://doi.org/10.30629/2613-6667-2013-79-95-99
Views:
1056
Email this article 
